Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results from the PIANO registry,” by Chugh R, Long MD, Jiang Y, Weaver KN, Beaulieu DB, Scherl EJ, Mahadevan U. Am J Gastroenterol. 2023 Oct 5. Epub ahead of print.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Nicole Rich, MD, MSCS discuss “A phase 3, randomized controlled trial of resmetirom in NASH with liver fibrosis,” by Harrison SA, Bedossa P, Guy CD et al. NEJM 2024; 390(6): 497-509.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Sonali Paul, MD discuss “Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events among Patients with Type 2 Diabetes Mellitus: A Scandinavian Cohort Study,” Engstom A, Wintzell V, Melbye M, et al. Hepatology 2024; In Press.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening,” by Chung DC, Gray DM, Singh H, et al. N Engl J Med 2024; 390: 973-83.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jeffrey Lee, MD, MPH discuss “Endoscopic En Bloc Versus Piecemeal Resection of Large Nonpedunculated Colonic Adenomas: A Randomized Comparative Trial,” by Jacques J, Schaefer M, Wallenhorst T, et al. Ann Intern Med 2024; 177: 29-38.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Philip Okafor, MD, MPH discuss “Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk among Older Adults,” by Liu PH, Singal AG, Murphy CC. Am J Gastroenterol 2024; 119: 353-63.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Timothy Yen, MD discuss “Personalised Surveillance for Serrated Polyposis Syndrome: Results from a Prospective 5-Year International Cohort Study,” by Bleijenberg AG, IJspeert JE, van Herwaarden YJ, et al. Gut 2020; 69: 112-21.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Association of Ultra-Processed Food Consumption with Colorectal Cancer Risk Among Men and Women,” by Wang L, Du M, Wang K, et al. BMJ 2022; 378:e068921.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MSCR discuss “Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study,” by Holmberg D, Giola S, von Euler-Chelpin M, et al. BMJ 2023; 382: e076017

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Joseph Elmunzer, MD, MSc discuss “Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised trial,” by Elmunzer BJ, Foster LD, Serrano J et al. Lancet 2024; 403: 450-58.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Ahmad Abu-Heija, MBBS discuss “Comparison of a novel, flavor-optimized, polyethylene glycol and sulfate bowel preparation with oral sulfate solution in adults undergoing colonoscopy,” by Summarizing Bhandari R, Goldstein M, Mishkin DS, et al. J Clin Gastroenterol; 2023;57(9):920-927.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Sonali Paul, MD discuss “Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial,” by Aronne LJ, Horn DB, Bays HE, et al. JAMA 2024; 3310: 38-48.

Philip Schoenfeld, MD, MSEd, MSc and Bharati Kochar, MD, MS discuss “Early Ileocecal Resection for Crohn’s Disease is Associated with Improved Long-Term Outcomes Compared with Anti-Tumor Necrosis Factor Therapy: A Population-Based Cohort Study,” by Agrawal M, Ebert AC, Poulsen G, et al. Gastroenterology 2023; 165:976-985.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jeffrey Lee, MD, MPH discuss “Root-cause Analysis of 762 Danish Post-colonoscopy Colorectal Cancer Patients,” by Troelsen FS, Sørensen HT, Pedersen L, Brix LD, Grode LB, Dekker E, Erichsen R. Clin Gastroenterol Hepatol. 2023 Nov;21(12):3160-3169.e5. Epub 2023 Apr 7.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Endoscopist-Level and Procedure-Level Factors Associated with Increased Adenoma Detection With the Use of a Computer-Aided Detection Device,” by Shaukat A, Lichtenstein DR, Chung DC, et al. Am J Gastroenterol 2023; 118: 1891-94.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis,” by D'Haens G, Dubinsky M, Kobayashi T, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Philip Okafor, MD, MPH discuss “Thalidomide for Recurrent Bleeding Due to Small Intestinal Angiodysplasia,” by Chen H, Wu S, Tang M et al. N Engl J Med 2023 Nov 2;389(18):1649-1659.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in Primary Care (ATLANTIS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial,” by Ford AC, Wright-Hughes A, Alderson S, et al. Lancet 2023; 402: 1773-85.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swati Patel, MD, MS discuss “Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial,” by Burn J, Sheth H, Elliot F, et al. Lancet 2020;395:1855-63.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Nicole Rich, MD, MSCS discuss “Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) study,” by Reddy KR, McLerran D, Marsh T et al. Gastroenterology 2023; 165(4): 1053-1063.e6.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Shria Kumar, MD, MSCE discuss “Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation,” by Marchegiani G, Pollini T, Burelli A, et al. Gastroenterology 2023 Oct;165(4):1016-1024.e5

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jennifer Kolb, MD, MPH discuss “Magnitude and Time-Trends of Post-Endoscopy Esophageal Adenocarcinoma and Post-Endoscopy Esophageal Neoplasia in a Population-Based Cohort Study: The Nordic Barrett's Esophagus Study,” by Wani S, Holmberg D, Santonin G, et al. Gastroenterology 2023; 165:909-19.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Sonali Paul, MD, MS discuss “Risk of Gastrointestinal Adverse Events Associated with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss,” by Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M. JAMA Medicine 2023; In Press.

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MS discuss “Etrasimod as Induction and Maintenance Therapy for Ulcerative Colitis (ELEVATE): Two Randomised, Double-Blind, Placebo-Controlled, Phase 3 Studies,” by Sandborn WJ, Vermeire S, Peyrin-Biroulet L, et al. Lancet 2023; 401: 1159-71.